Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Reporting results of cancer treatment
1981 • 7,916 citations
VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
1985 • 301 citations
Small-Cell Carcinoma of the Lung: Combined Chemotherapy and Radiation
1978 • 232 citations
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
1985 • 188 citations
Chemotherapy of Advanced Small-Cell Anaplastic Carcinoma
1978 • 110 citations
Podophyllotoxin derivative VP 16-213
1979 • 86 citations
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer
1984 • 68 citations
Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)
1977 • 58 citations
Small cell carcinoma of the lung
1986 • 39 citations
Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma
1980 • 28 citations
CLINICAL RESULTS WITH CISPLATIN IN LUNG CANCER
1980 • 19 citations